Drawing for TARGET RWE HEALTH EVIDENCE SOLUTIONS

USPTO serial 90133098

TARGET RWE HEALTH EVIDENCE SOLUTIONS

Reviewed by CopyMark Law Group

Reg. 6695120Status 700Registered
Filing date
Status date
Registration date
Apr 5, 2022
Examiner
NEPTUNE, EVONNE MARIE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with TARGET RWE HEALTH EVIDENCE SOLUTIONS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Shaun J. Bockert

Shaun J. Bockert BLANK ROME LLPONE LOGAN SQUARE8TH FLOORPHILADELPHIA, PA 19103

Goods and services

ClassDescriptionStatusFirst use
035Marketing consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Business services provided to the life sciences industry, namely, the collection, reporting, and analysis of healthcare quality data for business purposes; Data processing services in the field of post-marketing drug safety and surveillanceACTIVEAug 9, 2020
042Scientific research consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillance; Providing medical and scientific research information in the field of pharmaceuticals; Clinical research and testing services in the fields of pharmaceuticals; Product development consultation in the fields of pharmaceuticals; Consulting services in the field of pharmaceutical research; Medical and scientific research in the field of post-marketing drug safety and surveillance; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research services; Research in the field of pharmaceuticalsACTIVEAug 9, 2020
045Regulatory compliance consulting services for companies in the life sciences industry relating to post-marketing drug safety and surveillanceACTIVEAug 9, 2020

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (R.PR): Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.

DateCodeEventWhat it means
Apr 5, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 3, 2022SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 2, 2022CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Dec 1, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 19, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 19, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 17, 2021ALIEASSIGNED TO LIE—
Nov 12, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 11, 2021CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 7, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 19, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 7, 2021IUAFUSE AMENDMENT FILED—
Jul 7, 2021EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 2, 2021DOCKASSIGNED TO EXAMINER—
Jun 1, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 6, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 6, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 17, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 27, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 26, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 26, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 26, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 5, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 5, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 20, 2020DOCKASSIGNED TO EXAMINER—
Sep 29, 2020MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Sep 28, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance